Skip to main content
Log in

Use of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity

  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Drugs that act through noradrenergic and serotonergic mechanisms have historically served as the mainstays of pharmacologic treatments for obesity. This review addresses the following three topics: a brief discussion of older weight loss medications approved for short-term use (benzphetamine, phendimetrazine, diethylpropion, mazindol, and phentermine), as well as over-the-counter adrenergic drugs (phenylpro-panolamine and ephedrine); recent clinical studies documenting the safety and efficacy of a new medication for obesity treatment, sibutramine, recently approved by the Food and Drug Administration for long-term use; and recent studies characterizing the valvulopathy associated with fenfluramine and dexfenfluramine, serotonergic medications for obesity which have been removed from the markets.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. National Institutes of Health and National Heart, Lung and Blood Institute (1998). Obes. Res. 6, 51S-210S.

    Google Scholar 

  2. Bray, G. A. (1991). Ann. Intern. Med. 115, 152–153.

    PubMed  CAS  Google Scholar 

  3. Bray, G. A. (1999). Ann. Intern. Med. 31, 1–3.

    CAS  Google Scholar 

  4. Weintraub, M., Sundaresan, P. R., Madan, M., Schuster, B., Balder, A., Lasagna, L., and Cox, C. (1992). Clin. Pharmacol. Ther. 51, 586–594.

    Article  PubMed  CAS  Google Scholar 

  5. Weintraub, M., Sundaresan, P. R., Schuster, B., Ginsberg, G., Madan, M., Balder, A., Stein, E. C., and Byrne, L. (1992). Clin. Pharmacol. Ther. 51, 595–601.

    Article  PubMed  CAS  Google Scholar 

  6. Weintraub, M., Sundaresan, P. R., Schuster, B., Moscucci, M., and Stein, E. C. (1992). Clin. Pharmacol. Ther. 51, 602–607.

    Article  PubMed  CAS  Google Scholar 

  7. Weintraub, M., Sundaresan, P. R., Schuster, B., Averbuch, M., Stein, E. C., Cox, C., and Byrne, L. (1992). Clin. Pharmacol. Ther. 51, 608–614.

    Article  PubMed  CAS  Google Scholar 

  8. Weintraub, M., Sundaresan, P. R., Schuster, B., Averbuch, M., Stein, E. C., and Byrne, L. (1992). Clin. Pharmacol. Ther. 51, 615–618.

    Article  PubMed  CAS  Google Scholar 

  9. Connolly, H. M., Crary, J. L., McGoon, M. D., Hensrud, D. D., Edwards, B. S., Edwards, W. D., and Schaff, H. V. (1997). N. Engl. J. Med. 337, 581–588.

    Article  PubMed  CAS  Google Scholar 

  10. American Home Products Unveils Fen-Phen Settlement Plan. Reuters Health. (1999).

  11. Bray, G. A. and Greenway, F. L. (1999). Endocr. Rev. 20, 805–875.

    Article  PubMed  CAS  Google Scholar 

  12. Munro, J. F., MacCuish, A. C., Wilson, E. M., and Duncan, L. F. P. (1968). BMJ 1, 352–356.

    Article  PubMed  CAS  Google Scholar 

  13. Weintraub, M. (1985). Clin. Pharmacol. Ther. 5, 53–79.

    Google Scholar 

  14. Morgan, J. P. and Funderburk, F. R. (1992). Am. J. Clin. Nutr. 55, 206S-210S.

    PubMed  CAS  Google Scholar 

  15. Astrup, A., Breum, L., Toubro, S., Hein, P., and Quaade, F. (1992). Int. J. Obes. Relat. Metab. Disord. 16, 169–277.

    Google Scholar 

  16. Connoley, J. P., Liu, Y. L., Frost, I., Reckless, I. P., Heal, D. J., and Stock, M. J. (1999). Br. J. Pharmacol. 126, 1487–1495.

    Article  PubMed  CAS  Google Scholar 

  17. Stock, M. J. (1997). Int. J. Obes. 21, S25-S29.

    CAS  Google Scholar 

  18. Rolls, B. J., Shide, D. J., Thorwart, M. L., and Ulbrecht, J. S. (1998). Obes. Res. 6, 1–11.

    PubMed  CAS  Google Scholar 

  19. Chapelot, D., Marmonier, C., Thomas, F., and Hanotin, C. (2000). Physiol. Behav. 58, 299–308.

    Article  Google Scholar 

  20. Halford, J. L. G., Heal, D. J., and Blundell, J. E. (1994). Appetite 23, 306–307.

    Google Scholar 

  21. Seagle, H. M., Bessessen, D. H., and Hill, J. O. (1998). Obes. Res. 6, 115–121.

    PubMed  CAS  Google Scholar 

  22. Hansen, D. L., Toubro, S., Stock, M. J., Macdonald, I. A., and Astrup, A. (1998). Am. J. Clin. Nutr. 6, 1180–1186.

    Google Scholar 

  23. Hansen, D. L., Toubro, S., Stock, M. J., Macdonald, I. A., and Astrup, A. (1999). Int. J. Obes. Relat. Metab. Disord. 23, 1016–1024.

    Article  PubMed  CAS  Google Scholar 

  24. Walsh, K. M., Lean, E., and Lean, M. E. (1999). Int. J. Obes. Relat. Metab. Disord. 23, 1009–1015.

    Article  PubMed  CAS  Google Scholar 

  25. Weintraub, M., Rubio, A., Golik, A., Byrne, L., and Scheinbaum, M. L. (1991). Clin. Pharmacol. Ther. 50, 330–337.

    Article  PubMed  CAS  Google Scholar 

  26. Ryan, D. H., Kaiser, P., and Bray, G. A. (1995). Obes. Res. 3, 553–559.

    Google Scholar 

  27. Bray, G. A., Ryan, D. H., Gordon, D., Heidingsfelder, S., Cerise, F., and Wilson, K. (1996). Obes. Res. 4, 263–270.

    PubMed  CAS  Google Scholar 

  28. Lean, M. E. (1997). Int. J. Obes. 21, S30-S36.

    CAS  Google Scholar 

  29. Hanotin, C., Thomas, F., Jones, S. P., Leutenegger, E., and Drouin, P. (1998). Int. J. Obes. Relat. Metab. Disord. 22, 32–38.

    Article  PubMed  CAS  Google Scholar 

  30. Bray, G. A., Blackburn, G. L., Ferguson, J. M., Greenway, F. L., Jain, A. K., Mendel, C. M., Mendels, J., Ryan, D. H., Schwartz, S. L., Scheinbaum, M. L., and Seaton, T. B. (1999). Obes. Res. 7, 189–198.

    PubMed  CAS  Google Scholar 

  31. Apfelbaum, M., Vague, P., Ziegler, O., Hanotin, C., Thomas, F., and Leutenegger, E. (1999). Am. J. Med. 106, 179–184.

    Article  PubMed  CAS  Google Scholar 

  32. Cuellar, G. E., Ruiz, A. M., Monsalve, M. C., and Berber, A. (2000). Obes. Res. 8, 71–82.

    Article  PubMed  CAS  Google Scholar 

  33. Fanghanel, G., Cortinas, L., Sanchez-Reyes, L., and Berber, A. (2000). Int. J. Obes. Relat. Metab. Disord. 24, 144–150.

    Article  PubMed  CAS  Google Scholar 

  34. Bach, D. S., Rissanen, A. M., Mendel, C. M., Shepherd, G., Weinstein, S. P., Kelly, F., Seaton, T. B., Patel, B., Pekkarinen, T. A., and Armstrong, W. F. (1999). Obes. Res. 7, 363–369.

    PubMed  CAS  Google Scholar 

  35. Schuh, L. M., Schustser, C. R., Hopper, J. A., and Mendel, C. M. (2000). Psychopharmacology 147, 339–346.

    Article  PubMed  CAS  Google Scholar 

  36. James, P., Astrup, A., Finer, N., Hilsted, J. Kopelman, P., Rossner, S., Saris, W., and Van Gaal, L. (1999). Obes. Res. 7(Suppl. 1), 50S.

  37. Fujioka, K., Seaton, T. B., Rowe, E., Jelinek, C. A., Raskin, P., Lebovitz, H. E., Weinstein, S. P., and the Sibutramine/Diabetes Clinical Study Group. (2000). Diabetes, Obesity and Metabolism 2, 1–13.

    Article  Google Scholar 

  38. McMahon, F. G., Fujioka, K., Singh, B. N., Mendel, C. M., Rowe, E., Rolston, K., Johnson, F., and Mooradian, A. D. (2000). Arch. Intern. Med. 160, 2185–2191.

    Article  PubMed  CAS  Google Scholar 

  39. Rissanen, T., Pekkarinen, T., Heinanen, T., Saltevo, J., and Taskinen, M. R. (1999). Obes. Res. 7(Suppl. 1), 93S.

    Google Scholar 

  40. Griffiths, J., Byrnes, A. E., and Frost, G. (1995). Int. J. Obes. 19(Suppl. 2), 41.

    Google Scholar 

  41. Khan, M. A., Herzog, C. A., St. Peter, J. V., Hartley, G. G., Madlon-Kay, R., Dick, C. D., Asinger, R. W., and Vessey, J. T. (1998). N. Engl. J. Med. 339, 713–718.

    Article  PubMed  CAS  Google Scholar 

  42. Weissman, N. J., Tighe, J. F., Gottdiener, J. S. and Gwynne, J. T. (1998). for the Sustained-Release Dexfenfluramine study Group. N. Engl. J. Med. 339, 725–732.

    Article  PubMed  CAS  Google Scholar 

  43. Jick, H., Vasilakis, C., Weinrauch, L. A., Meier, C. R., Jick, S. S., and Derby, L. E. (1998). N. Engl. J. Med. 339, 719–724.

    Article  PubMed  CAS  Google Scholar 

  44. Wadden, T. A., Berkowitz, R. I., Silvestry, F., Vogt, R. A., St. John Sutton, M. G., Stunkard, A. J., Foster, G. D., and Aber, J. L. (1998). Obes. Res. 6, 278–284.

    PubMed  CAS  Google Scholar 

  45. Wee, C. C., Phillips, R. S., Aurigemma, G., Erban, S., Kriegel, G., Riley, M., and Douglas, P. S. (1998). Ann. Intern. Med. 129, 870–874.

    PubMed  CAS  Google Scholar 

  46. Ryan, D. H., Bray, G. A., Helmcke, F., Sander, G., Volaufova, J., Greenway, F., Subramaniam, P., and Glancy, D. L. (1999). Obes. Res. 7, 313–322.

    PubMed  CAS  Google Scholar 

  47. Connolly, H. M. and McGoon, M. D. (1999). Curr. Prob. Cardiol. 24, 751–792.

    Article  Google Scholar 

  48. Cannistra, L. B. and Cannistra, A. J. (1998). N. Engl. J. Med. 339, 771.

    Article  PubMed  CAS  Google Scholar 

  49. Hensrud, D. D., Conolly, H. M., Grogan, M., Miller, P. A., and Jensen, M. D. (1999). Mayo Clin. Proc. 74, 1302–1304.

    Google Scholar 

  50. Ryan, D. H., Bray, G. A., Greenway, F. L., and Helmcke, F. (1999). Obes. Res. 7(Suppl. 1), 50S.

    Google Scholar 

  51. Weyer, C., Gautier, J. F., and Danforth, E. (1999). Diabetes Metab. 25, 11–21.

    PubMed  CAS  Google Scholar 

  52. World Health Organization. (1998). Obesity-Preventing and Managing the Global Epidemic. Report of a WHO Consultancy on Obesity, Geneva, 3–5 June, 1997. WHO: Geneva.

    Google Scholar 

  53. Bray, G. A. (1998). Lancet 352, 160–161.

    Article  PubMed  CAS  Google Scholar 

  54. Colditz, G. A., and Coakley, E. (1997). Int. J. Sports Med. 18, S162-S170.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Donna H. Ryan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ryan, D.H. Use of sibutramine and other noradrenergic and serotonergic drugs in the management of obesity. Endocr 13, 193–199 (2000). https://doi.org/10.1385/ENDO:13:2:193

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/ENDO:13:2:193

Key Words

Navigation